scispace - formally typeset
Open AccessJournal Article

Establishment and characterization of a human prostatic carcinoma cell line (PC-3).

M E Kaighn, +4 more
- 01 Jul 1979 - 
- Vol. 17, Iss: 1, pp 16-23
TLDR
The establishment, characterization, and tumorigenicity of a new epithelial cell line (PC-3) from a human prostatic adenocarcinoma metastatic to bone is reported, which should be useful in investigating the biochemical changes in advanced prostatic cancer cells and in assessing their response to chemotherapeutic agents.
Abstract
The establishment, characterization, and tumorigenicity of a new epithelial cell line (PC-3) from a human prostatic adenocarcinoma metastatic to bone is reported The cultured cells show anchorage-independent growth in both monolayers and in soft agar suspension and produce subcutaneous tumors in nude mice Culture of the transplanted tumor yielded a human cell line with characteristics identical to those used initially to produce the tumor PC-3 has a greatly reduced dependence upon serum for growth when compared to normal prostatic epithelial cells and does not respond to androgens, glucocorticoids, or epidermal or fibroblast gowth factors Karyotypic analysis by quinacrine banding revealed the cells to be completely aneuploid with a modal chromosome number in the hypotriploid range At least 10 distinctive marker chromosomes were identified The overall karyotype as well as the marker chromosomes are distinct from those of the HeLa cell Electron microscopic studies revealed many features common to neoplastic cells of epithelial origin including numerous microvilli, junctional complexes, abnormal nuclei and nucleoli, abnormal mitochondria, annulate lamellae, and lipoidal bodies Overall, the functional and morphologic characteristics of PC-3 are those of a poorly-differentiated adenocarcinoma These cells should be useful in investigating the biochemical changes in advanced prostatic cancer cells and in assessing their response to chemotherapeutic agents

read more

Citations
More filters
Journal ArticleDOI

Androgen receptors and hormone sensitivity of a human prostatic cancer cell line (PC-3) are modulated by natural beta-interferon

TL;DR: The anti androgen hydroxyflutamide shows agonistic properties by increasing the cell number of PC-3 cells pre-exposed to β-IFN, and when the antiandrogen is tested in combination with interferon, it produces a reduction in the β- IFN-induced inhibition of cell growth.
Journal ArticleDOI

Tumor Characterization with Dynamic Contrast Enhanced Magnetic Resonance Imaging and Biodegradable Macromolecular Contrast Agents in Mice

TL;DR: The polydisulfide-based biodegradable macromolecular MRI contrast agents are promising in tumor characterization and differentiation with dynamic contrast enhanced MRI.
Journal ArticleDOI

[11C]Choline as pharmacodynamic marker for therapy response assessment in a prostate cancer xenograft model.

TL;DR: In this article, the effect of [11C] choline on the effects of therapy in a prostate cancer mouse xenograft model was investigated. And the results demonstrate that [11c]choline has the potential for use in the early monitoring of the therapeutic effect of docetaxel in prostate cancer patients.
Journal ArticleDOI

Estrogens down-regulate the stem cell factor (SCF)/c-KIT system in prostate cells: Evidence of antiproliferative and proapoptotic effects.

TL;DR: It is demonstrated that E2 down-regulated the expression of SCF/c-KIT system in prostate cells, which was associated with antiproliferative and proapoptotic effects, which support the protective role of estrogens in PCa and open new perspectives on the application of estrogen-based therapies.
Journal ArticleDOI

The effect of hyperthermia on human prostatic carcinoma cell lines: evaluation in vitro.

TL;DR: In vitro results indicate that hyperthermia may become a potentially useful form of adjunctive therapy for local control of prostatic cancer, however, the temperature and exposure time may have an important impact on cell kill when this new modality for cancer treatment is proposed for a clinical trial.
Related Papers (5)